HSBC downgrades Illumina on China risks, funding concerns
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- S&P 500 ends marginally lower as investors focus on US-Iran war
Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
March 4, 2025 12:52 PM ESTCanaccord Genuity analyst Kyle Mikson reiterated a Hold rating and $135.00 price target on Illumina (NASDAQ: ILMN).
The analyst comments "We reiterate our HOLD rating on Illumina (ILMN) shares and maintain our price target at $135. Before the market open on Tuesday, March 4, China's Ministry of Commerce (MOFCOM)... More
Barclays Reiterates Underweight Rating on Illumina (ILMN), PT $100
March 4, 2025 10:06 AM ESTBarclays analyst Luke Sergott reiterated an Underweight rating and $100.00 price target on Illumina (NASDAQ: ILMN).
The analyst comments "The biggest fear for Tools investors re China tariffs is on how China retaliates. The first shot, indicated weeks ago (see our report HERE, as well as the Reuters article HERE), hits ILMN, with China announcing a ban in effect starting today. On first... More
Evercore ISI Reiterates Outperform Rating on Illumina (ILMN)
March 4, 2025 9:57 AM ESTEvercore ISI analyst Vijay Kumar reiterated an Outperform rating and $160.00 price target on Illumina (NASDAQ: ILMN)
The analyst comments "Bottomline: Policy uncertainty makes it hard for businesses to investand ILMNs ~40% slide in past month has captured it relative to others. We think ILMN should find support once China news gets priced in. Our Take #1: Assuming zero China revs, EPS HW could be ~50c (assuming no cost actions) As seen from Fig 1, we assumed China OM to be double that of corporate... More
Stifel Reiterates Buy Rating on Illumina (ILMN)
March 4, 2025 9:52 AM ESTStifel analyst Daniel Arias reiterated a Buy rating and $160.00 price target on Illumina (NASDAQ: ILMN).
The analyst comments "One month after adding ILMN to the unreliable entities list as an act of retaliation against the US increasing tariffs on China, China today announced that a penalty for being on that list for ILMN is they are now prohibited from exporting gene sequencers to China. This does not appear to prohibit sales of consumables or services to the region, which represents the vast majority of ILMN's China revenues. ILMN management had stated... More
Wolfe Research Reiterates Outperform Rating on Illumina (ILMN), PT $150
March 4, 2025 9:51 AM ESTWolfe Research analyst Doug Schenkel reiterated an Outperform rating and $150.00 price target on Illumina (NASDAQ: ILMN)
The analyst comments "Overnight, China banned ILMN from importing sequencers into the country. The company is working to assess the potential impact and continues to... More
Leerink Partners on Illumina (ILMN), 'optics is likely to affect customer willingness to buy'
March 4, 2025 9:45 AM ESTLeerink Partners analyst Puneet Souda reiterated an Outperform rating and $150.00 price target on Illumina (NASDAQ: ILMN)
The analyst comments "Bottom Line: This morning, China announced a ban on importing ILMN's sequencers. The action is unlikely to come as a surprise and part of retaliatory actions after China placed ILMN on the Unreliable Entity List (UEL) in early February. ILMN kept the China revenue intact after the prior UEL announcements - citing... More
Citi Opens 90-Day Downside Short-term View on Illumina (ILMN)
March 4, 2025 7:18 AM ESTCiti Opens 90-Day Downside Short-term View on Illumina (NASDAQ: ILMN).
The analyst comments "ILMN is facing multiple headwinds given recent developments. To start, ILMN was placed on Chinas "unreliable entities" list earlier this year, in Chinas response against new... More
